MA54866A - Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques - Google Patents
Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiquesInfo
- Publication number
- MA54866A MA54866A MA054866A MA54866A MA54866A MA 54866 A MA54866 A MA 54866A MA 054866 A MA054866 A MA 054866A MA 54866 A MA54866 A MA 54866A MA 54866 A MA54866 A MA 54866A
- Authority
- MA
- Morocco
- Prior art keywords
- triterpenoid
- antifungals
- fungal
- treatment
- osteoarticular infections
- Prior art date
Links
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 230000002538 fungal effect Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798743P | 2019-01-30 | 2019-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54866A true MA54866A (fr) | 2022-05-04 |
Family
ID=69740705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054866A MA54866A (fr) | 2019-01-30 | 2020-01-30 | Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20220117948A1 (https=) |
| EP (1) | EP3917534B1 (https=) |
| JP (1) | JP7562542B2 (https=) |
| CN (1) | CN113498343A (https=) |
| EA (1) | EA202192107A1 (https=) |
| MA (1) | MA54866A (https=) |
| WO (1) | WO2020160316A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020276595B2 (en) * | 2019-05-16 | 2025-12-04 | Scynexis, Inc. | Antifungal Agents for Candida Auris Decolonization |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| JP5245057B2 (ja) | 2006-04-03 | 2013-07-24 | メルク・シャープ・アンド・ドーム・コーポレーション | 抗真菌剤 |
| WO2010019204A1 (en) * | 2008-08-12 | 2010-02-18 | Merck Sharp & Dohme Corp. | Antifungal agents |
| KR101686075B1 (ko) * | 2008-08-12 | 2016-12-13 | 싸이넥시스, 인크. | 항균제 |
| WO2018102407A1 (en) * | 2016-11-29 | 2018-06-07 | Cidara Therapeutics, Inc | Methods for preventing fungal infections |
-
2020
- 2020-01-30 US US17/425,941 patent/US20220117948A1/en not_active Abandoned
- 2020-01-30 MA MA054866A patent/MA54866A/fr unknown
- 2020-01-30 EP EP20708913.7A patent/EP3917534B1/en active Active
- 2020-01-30 EA EA202192107A patent/EA202192107A1/ru unknown
- 2020-01-30 CN CN202080014666.6A patent/CN113498343A/zh active Pending
- 2020-01-30 WO PCT/US2020/015948 patent/WO2020160316A1/en not_active Ceased
- 2020-01-30 JP JP2021544218A patent/JP7562542B2/ja active Active
-
2024
- 2024-11-20 US US18/954,519 patent/US20250248983A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220117948A1 (en) | 2022-04-21 |
| JP7562542B2 (ja) | 2024-10-07 |
| EA202192107A1 (ru) | 2021-10-21 |
| JP2022519500A (ja) | 2022-03-24 |
| CN113498343A (zh) | 2021-10-12 |
| EP3917534A1 (en) | 2021-12-08 |
| US20250248983A1 (en) | 2025-08-07 |
| EP3917534B1 (en) | 2024-07-03 |
| WO2020160316A1 (en) | 2020-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45539A (fr) | Dihydropyranopyrimidines pour le traitement d'infections virales | |
| EP3641829A4 (en) | INTERFERON PRODRUG FOR TREATMENT OF CANCER | |
| EP3431105A4 (en) | MEDICAL COMPOSITION FOR THE TREATMENT OF CANCER | |
| MA47719A (fr) | Esketamine pour le traitement de la dépression | |
| EP3908270A4 (en) | COMBINATION OF DEXTROMETHORPHANE AND BUPROPION FOR THE TREATMENT OF DEPRESSION | |
| EP3426258A4 (en) | CATIONIC STEROIDAL ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF SKIN TISSUE | |
| EP3691639A4 (en) | CHROMAN MONOBACTAM COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTION | |
| MA44083A (fr) | Composés de biarylmonobactame pour le traitement d'infections bactériennes | |
| EP3645040A4 (en) | USE OF ANTI-FAM19A5 ANTIBODIES FOR CANCER TREATMENT | |
| EP3946357A4 (en) | TOPICAL FORMULATIONS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES | |
| MA49576A (fr) | Compositions et méthodes pour le traitement d'infections fongiques | |
| MA55218A (fr) | Eskétamine pour le traitement de la dépression | |
| MA43825A (fr) | Schémas posologiques pour le traitement d'infections fongiques | |
| EP3374350A4 (en) | HYDROXYPYRIDINONE- AND HYDROXYPYRIMIDINONE-BASED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
| EP3655404A4 (en) | COMPOUNDS AND THEIR USE TO TREAT MICROBIAL INFECTIONS | |
| EP3773221A4 (en) | TREATMENT OF HYDROCEPHALUS | |
| EP3541379A4 (en) | COMPOSITIONS FOR THE TREATMENT OF HYPERTONIA | |
| EP3541417A4 (en) | Combination immunotherapies for treatment of cancer | |
| EP3766497A4 (en) | Drug for treating cough | |
| EP3716966A4 (en) | ALPHA-KETO ACID COMPOSITIONS FOR THE TREATMENT OF HYPOALBUMINEMIA | |
| EP3344325A4 (en) | LOCAL ADMINISTRATION OF MEDICAMENTS FOR THE TREATMENT OF ASTHMA | |
| EP3947460A4 (en) | MULTISPECIFIC AGENTS FOR TREATMENT OF CANCER | |
| EP3630080A4 (en) | USE OF EZH2 INHIBITORS TO TREAT CANCER | |
| MA45334A (fr) | Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes | |
| EP3612214A4 (en) | ENZYME REPLACEMENT THERAPY OPTIMIZATION FOR THE TREATMENT OF HOMOCYSTINURIA |